Brian Luque

Brian Luque is an accomplished executive in investor relations and corporate development, currently serving as Executive Director and Head of Investor Relations and Corporate Development at Fractyl Health since January 2025. Luque has extensive experience, previously holding roles such as Senior Director of Business Development and Investor Relations and Director of Business Development and External Alliances at Ring Therapeutics, along with a tenure as Director of Investor Relations at Inozyme Pharma and Associate Director of Investor Relations at LogicBio Therapeutics. Luque also contributed to the NIRI Boston Chapter as a board member. Educational background includes a Bachelor of Science in Management Science from the Massachusetts Institute of Technology.